Announcements Trials
Browse Landscape

Phase

Phase 2 22Phase NA 6Phase 2/3 5Phase 1/2 5Phase 3 4Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 4Stomach Neoplasms 3Triple Negative Breast Neoplasms 2Advanced Solid Tumor 2Advanced Cancer 2Solid Tumor, Adult 1Recurrence 1Ovarian Neoplasms 1Neoplasm Metastasis 1NSCLC 1Mouth Neoplasms 1Extensive Stage Small Cell Lung Cancer 1Esophageal Squamous Cell Carcinoma 1Cytochrome P450 Interaction 1Colorectal Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Biliary Tract Malignancies 1Adenocarcinoma of Lung 1Adenocarcinoma 1

Interventions

Sorafenib 37Nivolumab 21pembrolizumab 18Bevacizumab 12Cyclophosphamide 10durvalumab 9fludarabine 8atezolizumab 8Magnetic Resonance Spectroscopy 8lenvatinib 7Radiosurgery 7Ipilimumab 7Radiotherapy 6Irinotecan 6Oxaliplatin 5Leucovorin 5tremelimumab 4toripalimab 4tislelizumab 4sintilimab 4cabozantinib 4budigalimab 4Specimen Handling 4Sirolimus 4Interleukin-2 4Fluorouracil 4Doxorubicin 4Capecitabine 4130-nm albumin-bound paclitaxel 4spartalizumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Carcinoma, Hepatocellular × apatinib × Clear all
NCT04665362 2021-01-22

IIT Study of M1-c6v1 Combined With SHR-1210 and Apatinib in Patients With HCC

Third Affiliated Hospital, Sun Yat-Sen University

Phase 1 Unknown
10 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡